ACET · Adicet Bio, Inc.
$8.21
+0.01 (+0.06%)
At close · Jul 29
Market Cap
$76.66M
Shares
9.35M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-04-09 | OrbiMed Genesis Master Fund, L.P. | Shareholder | 78,499 | 2026-04-09 | Themis Trading LLC |
| 2026-04-08 | OrbiMed Israel Partners II, L.P. | Shareholder | 40,416 | 2026-04-08 | Themis Trading LLC |
| 2026-04-07 | OrbiMed Israel Partners Limited Partnership | Shareholder | 64,242 | 2026-04-07 | Themis Trading LLC |
| 2024-06-05 | Kauffman Michael | Director | 5,900 | 2024-06-05 | Morgan Stanley Smith Barney LLC Executive Services |
| 2023-09-29 | CHEN SCHOR | Officer, Director | 5,500 | 2023-09-29 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–5 of 5 filings